Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SMART TRENDS Study

← catalyst calendar

NCT05957406

Sponsored by Becton, Dickinson and Company (industry) · BDX — their whole pipeline →.

Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Non randomized · None · Other
Enrollment
296actual
Sites
8
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-07-11actualWhen the study began enrolling
Primary completion2025-10-27actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-10-27actualThe whole study's end, after follow-up
First posted2023-07-24actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-07-08actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Moderate to High-risk Noncardiac Surgery

Interventions

  • Device: Acumen HPI Smart Alerts and Smart Trends Software
  • Device: The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff

Primary outcome

what the primary-completion date above is the date OF
HPI Smart Alert
measured From start to end of non-cardiac surgery

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · BDX's whole pipeline · Catalyst calendar · Every registered study · What changed